MedTrace Logo

Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients

NCT04325048 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2023-12-12

No results posted yet for this study

Summary

Study on adult patients positive to COVID-19 virus. After signing informed consent and undergoing screening assessments, eligible patients will record few times a day several pre-defined sentences to the Cordio App installed in a smartphone/tablet.

The app will upload the vocal data to the sponsor's servers for analysis. The patient will record at hospital admittance (COVID-19 positive) until patient defined as COVID-19 negative and free of relevant clinical symptoms.

Conditions

  • Coronavirus Infection

Interventions

DEVICE

Cordio App

Adult patients positive to COVID-19 virus will record several predefined sentences via a smartphone / tablet and will answer questions via the app

Sponsors & Collaborators

  • Cordio Medical

    lead INDUSTRY

Principal Investigators

  • Zaher Azzam, Prof · Rambam Health Care Campus

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-23
Primary Completion
2021-05-02
Completion
2021-09-29

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04325048 on ClinicalTrials.gov